Green Thumb Industries Inc. Faces Trading Halt and Resumption

Green Thumb Industries Inc., a prominent player in the pharmaceutical sector specializing in medical marijuana and cannabis products, experienced a notable trading halt on April 30, 2025. The company, which operates primarily in the United States, saw its trading activities temporarily suspended by the Canadian Investment Regulatory Organization (CIRO) due to a single stock circuit breaker. This halt occurred at 11:57 AM ET and was lifted shortly thereafter at 12:02 PM ET, allowing trading to resume.

The trading halt was reported by multiple financial news sources, including CEO.ca and Finanzen.net, highlighting the regulatory measures in place to ensure fair and orderly trading. Such halts are typically triggered by significant price movements and are intended to prevent panic selling or buying, thereby stabilizing the market.

In addition to the trading halt, Green Thumb Industries announced the opening of its 104th retail location, the Rise Dispensary Ocala in Florida, set to open on April 29, 2025. This expansion underscores the company’s growth strategy within the cannabis retail sector. The news was covered by several outlets, including StockWatch.com and OTCMarkets.com, emphasizing the company’s ongoing efforts to increase its market presence.

As of April 28, 2025, Green Thumb Industries’ stock was trading at $5.89, with a 52-week high of $14.318 and a low of $4.63. The company’s market capitalization stood at approximately $1.81 billion USD, with a price-to-earnings ratio of 20.46.

These developments reflect both the regulatory environment and growth trajectory of Green Thumb Industries Inc. as it continues to expand its footprint in the cannabis industry.